My Pitch: "Our basis is $2.29. I am confident of share price increase predicated on upcoming catalysts at FDA, recent financing and potential buy-out. Doubled holdings on 11/07/2013. Takeda agrees to acquire ARIA: $24/share
http://tinyurl.com/jrahcmc
"

My Pitch: "Aria"

My Pitch: "http://www.barchart.com/charts/stocks/ARIA NEWS VOL ALERT CHART 8.94 1.31 (+17.17%)Tue, Aug 9th, 2011 "

My Pitch: "Phot"

My Pitch: "Target 33$ TSL 25.75$
EPIC Q3 2014
"

My Pitch: "Aria"

My Pitch: "Poss phizer buyout"

My Pitch: "Aria"

My Pitch: "Aria
"

My Pitch: "Aria
"

My Pitch: "Love it"

My Pitch: "Money making since 2009. Do you own DD. Mucho volatility....:) "

My Pitch: "Happy Birthday Matthew."

My Pitch: "Exel"

My Pitch: "Aria"

My Pitch: "Within days should breach $8."

My Pitch: "Yes"

My Pitch: "Aria"

My Pitch: "New drugs such as gefitinib and erlotinibdirectly target the EGFR. Patients have been divided into EGFR-positive and EGFR-negative, based upon whether a tissue test shows a mutation. EGFR-positive patients have shown a 60% response rate, which exceeds the response rate for conventional chemotherapy."

My Pitch: "Takeover candidate "

My Pitch: "Ok"

My Pitch: "Go up"

My Pitch: "Ariad pharmaceuticals"

My Pitch: "Ariad"

My Pitch: "Ariad"

My Pitch: "ARIA"

My Pitch: "Go"

My Pitch: "
"

My Pitch: "Aria"

My Pitch: "Not a one hit wonder"